A. Bernhardt

combination with all-trans retinoic acid Treatment of myelodysplastic syndromes with valproic acid alone or in

U. Germing, R. Haas, M. Aivado, 2013 .

Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid.

U. Germing, R. Haas, M. Aivado, 2004, Blood.

Early recurrence of rheumatoid arthritis after nonmyeloablative allogeneic blood stem cell transplantation in a patient with multiple myeloma

G. Kobbe, R. Fenk, R. Haas, 2003, Bone Marrow Transplantation.

Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study

W. Hiddemann, A. Schuh, P. Johansson, 2018, Haematologica.

Distinguishing myelodysplastic syndromes (MDS) from idiopathic cytopenia of undetermined significance (ICUS): HUMARA unravels clonality in a subgroup of patients.

U. Germing, R. Haas, M. Aivado, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Transplantation of allogeneic CD34+-selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemia.

U. Steidl, U. Germing, G. Kobbe, 2004, Cytotherapy.

P-29 RA and RARS with thrombocytosis:Mixed myelodysplastic/myeloproliferative disorder?

U. Germing, R. Haas, N. Gattermann, 2005 .

Levels of minimal residual disease detected by quantitative molecular monitoring herald relapse in patients with multiple myeloma.

U. Steidl, G. Kobbe, U. Rohr, 2004, Haematologica.

Rituximab in combination with bendamustine or chlorambucil for the treatment of chronic lymphocytic leukemia: primary results from the randomised phase IIIb MABLE study

W. Hiddemann, A. Schuh, P. Johansson, 2015 .

Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid.

U. Germing, R. Haas, M. Aivado, 2004, Blood.